US NATIONAL CANCER INSTITUTE: Scientists are making progress towards finding a life-extending treatment option for men with metastatic castration-resistant prostate cancer. READ MORE>

Read Full Post »

URO TODAY: Researchers have discovered that prostate tumours in mice can cause immune cells known as CD8+ T cells to change to cells that suppress immune responses. READ MORE>

This finding, by researchers at the US National Cancer Institute, has important implications for the design of immune-based therapies for cancer.

Future work by this team will focus on defining the mechanisms by which  gain their suppressive functions.

“This will enhance our ability to generate more effective anti-tumor T cell responses in mice, which then might be translated to human.”

Read Full Post »

JUNE 5:  US NATIONAL CANCER INSTITUTE: Treatment vaccines that boost the immune system’s response to tumours may have important clinical benefits for patients with various types of cancer, according to results from several clinical trials presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando. READ MORE>

Read Full Post »